Eli Lilly has launched a new software that will allow self-spend people to purchase the weight-loss drug Zepbound for as very little as $399 a month—a lot less than fifty percent the record price of other incretin medicines useful for patients with obesity.Together with the announcement of its new system, Lilly also produced an “open up letter�… Read More